Skip to Content

Takeda Pharmaceutical Co Ltd ADR TAK

Morningstar Rating
$13.28 +0.06 (0.45%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TAK is trading at a 856% premium.
Price
$13.27
Fair Value
$81.54
Uncertainty
High
1-Star Price
$73.82
5-Star Price
$67.33
Economic Moat
Yczsp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TAK is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$13.22
Day Range
$13.2613.33
52-Week Range
$12.7716.47
Bid/Ask
$13.11 / $13.47
Market Cap
$41.67 Bil
Volume/Avg
594,402 / 1.6 Mil

Key Statistics

Price/Earnings (Normalized)
14.17
Price/Sales
1.43
Dividend Yield (Trailing)
2.40%
Dividend Yield (Forward)
4.79%
Total Yield
2.45%

Company Profile

Takeda Pharmaceutical is Japan��s largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company’s five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Large Core
Total Number of Employees
49,095

Competitors

Valuation

Metric
TAK
4568
4519
Price/Earnings (Normalized)
14.1749.0326.47
Price/Book Value
0.876.285.05
Price/Sales
1.436.638.00
Price/Cash Flow
6.9740.5124.93
Price/Earnings
TAK
4568
4519

Financial Strength

Metric
TAK
4568
4519
Quick Ratio
0.462.744.21
Current Ratio
1.063.495.53
Interest Coverage
1.9311.76
Quick Ratio
TAK
4568
4519

Profitability

Metric
TAK
4568
4519
Return on Assets (Normalized)
2.86%7.33%17.64%
Return on Equity (Normalized)
6.13%13.01%21.05%
Return on Invested Capital (Normalized)
4.78%11.32%20.98%
Return on Assets
TAK
4568
4519
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AWmdrwycgbZdk$79.4 Bil
MKKGY
Merck KGaA ADRHcsbydcgkKxgbfjp$79.0 Bil
HLN
Haleon PLC ADRTkwcnsknFpy$38.1 Bil
VTRS
Viatris IncRrklbgxzQzm$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRWmwdcpvLjchj$11.6 Bil
CTLT
Catalent IncKqffvbgcvQshxkt$10.0 Bil
CURLF
Curaleaf Holdings IncGlxyfnwbrHfht$4.2 Bil
PRGO
Perrigo Co PLCVcvxrkjpdHpq$4.0 Bil
PBH
Prestige Consumer Healthcare IncSbwcwdnnjKvbrrv$3.2 Bil
GTBIF
Green Thumb Industries IncFgnpprchhNkcs$3.1 Bil

Sponsor Center